Question · asked by 1 review

Epidermal growth factor (EGF), oral spray vs placebo: Interruptions to cancer treatment (radiotherapy breaks longer than two days)

Epidermal growth factor (EGF), oral spray showed no clear difference in interruptions to cancer treatment (radiotherapy breaks longer than… compared with placebo; GRADE not reported.

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Epidermal growth factor (EGF), oral spray vs Placebo
Interruptions to cancer treatment (radiotherapy breaks longer than two days) · Adults with cancer receiving treatment · Radiotherapy to the head and neck
Epidermal growth factor (EGF), oral spray showed no clear difference in interruptions to cancer treatment (radiotherapy breaks longer than… compared with placebo; GRADE not reported.
Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and… (2017) · Cochrane All outcomes
RR 4.38 [0.25, 75.44]1 study · 113 participantsGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors
2017 · Cochrane All outcomes
2017-05list not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.